ARWR

#833
Arrowhead Research Corporation
63.2700
+2.54%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
63.2700
63.2700
Годовой диапазон
37.0600
76.7600
Дневное изменение
+2.54%
Месячное изменение
-5.44%
6-месячное изменение
+61.82%
Годовое изменение
+61.82%
Предыдущее закрытие
61.7000
Open
63.2700
Bid
Ask
Low
63.2700
High
63.2700
Объем
198
Open full chart

Financials

Overview Отчетность Statistics Dividends
Quarterly Annual
  • Market Capitalization 8.6705 B
  • Employee 711
  • Founded 2004
  • CEO Christopher Richard Anzalone
  • Website www.arrowheadpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000BRVKH0
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3 449
Price to sales ratio
5.56
Dividends per share
—
Dividend yield %
—

Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.

Новости